XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Revenue (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Revenue from Contract with Customer [Abstract] |
Schedule of Total Revenue by Category and by U.S versus Rest of World | The following table presents detail regarding the composition of the Company’s total revenue by type and by U.S. versus rest of world (“RoW”):
| Three months ended September 30,
| 2022 |  |  | 2021
(in millions) | U.S. |  | RoW |  | Total |  |  | U.S. |  | RoW |  | Total
Molecular diagnostic revenues: |  |  |  |  |  |  |  |  |  |  |  |
Hereditary Cancer | $ | 60.2 |  |  | $ | 10.3 |  |  | $ | 70.5 |  |  |  | $ | 68.2 |  |  | $ | 11.2 |  |  | $ | 79.4 |
Tumor Profiling | 20.2 |  |  | 10.6 |  |  | 30.8 |  |  |  | 21.3 |  |  | 11.6 |  |  | 32.9 |
Prenatal | 21.9 |  |  | 0.2 |  |  | 22.1 |  |  |  | 23.5 |  |  | 0.1 |  |  | 23.6 |
Pharmacogenomics | 33.0 |  |  | — |  |  | 33.0 |  |  |  | 24.1 |  |  | — |  |  | 24.1 |
Autoimmune | — |  |  | — |  |  | — |  |  |  | 7.3 |  |  | — |  |  | 7.3 |
Total molecular diagnostic revenue | 135.3 |  |  | 21.1 |  |  | 156.4 |  |  |  | 144.4 |  |  | 22.9 |  |  | 167.3 |
Total revenue | $ | 135.3 |  |  | $ | 21.1 |  |  | $ | 156.4 |  |  |  | $ | 144.4 |  |  | $ | 22.9 |  |  | $ | 167.3 |
| Nine months ended September 30,
| 2022 |  |  | 2021
(in millions) | U.S. |  | RoW |  | Total |  |  | U.S. |  | RoW |  | Total
Molecular diagnostic revenues: |  |  |  |  |  |  |  |  |  |  |  |
Hereditary Cancer | $ | 190.6 |  |  | $ | 30.0 |  |  | $ | 220.6 |  |  |  | $ | 207.1 |  |  | $ | 34.4 |  |  | $ | 241.5 |
Tumor Profiling | 61.4 |  |  | 35.5 |  |  | 96.9 |  |  |  | 63.4 |  |  | 31.0 |  |  | 94.4 |
Prenatal | 86.7 |  |  | 0.6 |  |  | 87.3 |  |  |  | 76.3 |  |  | 0.4 |  |  | 76.7 |
Pharmacogenomics | 95.5 |  |  | — |  |  | 95.5 |  |  |  | 64.3 |  |  | — |  |  | 64.3 |
Autoimmune | 0.3 |  |  | — |  |  | 0.3 |  |  |  | 28.2 |  |  | — |  |  | 28.2 |
Other | — |  |  | — |  |  | — |  |  |  | 0.5 |  |  | — |  |  | 0.5 |
Total molecular diagnostic revenue | 434.5 |  |  | 66.1 |  |  | 500.6 |  |  |  | 439.8 |  |  | 65.8 |  |  | 505.6 |
Pharmaceutical and clinical services revenue | — |  |  | — |  |  | — |  |  |  | 24.2 |  |  | — |  |  | 24.2 |
Total revenue | $ | 434.5 |  |  | $ | 66.1 |  |  | $ | 500.6 |  |  |  | $ | 464.0 |  |  | $ | 65.8 |  |  | $ | 529.8 |
Reconciliation of Deferred Revenue Balances | A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:
| Nine months ended September 30,
(in millions) | 2022 |  |  | 2021
Deferred revenue - beginning balance | $ | 5.2 |  |  |  | $ | 32.7 |
Revenue recognized | (5.3) |  |  |  | (30.3) |
Prepayments | 0.3 |  |  |  | 10.1 |
Held for sale reclassification | — |  |  |  | (1.0) |
Deferred revenue - ending balance | $ | 0.2 |  |  |  | $ | 11.5 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration